NL-OMON42376已完成不适用
The innate immune system in atherosclerosis - II - ISA-II
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 340
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- aged 18 years or older
- •- diagnosis of a known lipid disorder (including but not limited to hypercholestoremia, hypertriglyceridemia, combined hyperlipidemia, hypoalphalipoprotenemia, hypobetalipoprotenemia);Control group:
- •- Age >18 years
- •- No previous cardiovascular events
- •- No medication use
排除标准
- •Both groups:
- •- Known malignant disorders or any clinically significant medical condition that could interfere with the conduct of the study in the opinion of the investigator.
- •- Inability or unwillingness to comply with the protocol requirements, or deemed by investigator to be unfit for the study.
- •- History of cardiovascular event within the last 3 months
- •- Clinical signs of acute infection
研究者
相似试验
已完成
不适用
The Innate Immune System in Atherosclerosisarterial wall thickening100126531000381610003216atherosclerosisNL-OMON40196Academisch Medisch Centrum240
招募中
不适用
Atherosclerosis and the Innate immune system in patients with Diabetesarterial wall thickening1001842410003216atherosclerosisNL-OMON44284Academisch Medisch Centrum640
进行中（未招募）
不适用
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular DiseasesSystemic Lupus ErythematosusNCT04276701University Hospital, Bordeaux500
尚未招募
不适用
Innate immunity and vascular complications in type II diabetic South-Asian immigrantsnephropathydiabetes100110821004706010029149retinopathycardiovascular diseaseNL-OMON30311Academisch Medisch Centrum169
Unknown
不适用
Investigating Atherosclerosis In Seronegative SpondyloarthropathyIn Seronegative SpondyloarthropathyNCT04891783Sohag University120